Table 4.
T1 |
T2 |
||||
---|---|---|---|---|---|
Univariate Analysisa |
Univariate Analysisa |
Multivariate Analysisb |
|||
Independent variables | p-value | p-value | Odds ratio | 95%CI | p-value |
Sex | |||||
Female vs Male | 0.35 | 0.049 | 0.11 | 0.02–0.76 | 0.03 |
Preoperative chemotherapy | 0.26 | 0.55 | |||
Preoperative radiochemotherapy | 0.06 | 0.39 | |||
Preoperative radiotherapy | 0.40 | 0.27 | |||
T stage | |||||
T1 vs T2 vs T3 vs T4 | 0.82 | 0.73 | |||
Lymphovascular invasion | |||||
Yes vs No | 1.01 | 0.72 | |||
Stage | |||||
Stage I vs II vs III vs IV | 0.84 | 0.36 | |||
Vascular invasion | |||||
Yes vs No | 1.01 | 0.03 | NS | ||
Perineural invasion | |||||
Yes vs No | 1 | 0.71 | |||
Metastatic disease | |||||
Yes vs No | 1.01 | 0.25 | |||
Tumor grade | |||||
Grade 1 vs Grade 2 vs Grade 3 | 0.28 | 0.44 | |||
Tumor location | |||||
Colon vs rectum | 0.20 | 0.04 | 9.18 | 1.22–69.02 | 0.01 |
Positive lymph nodes | |||||
0–1 vs > 1 | 0.74 | 0.04 | NS |
aChi-square test or Fisher’s exact test when appropriate; b Multivariate logistic regression; Hosmer–Lemeshow p = 0.22 (>0.05).
CI, confidence interval; NS, not significant.